Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2022-07-15

Clinical Trial Update: Metabolic Pathways of GRA in Patients With Type 1 Diabetes [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update describing metabolic pathways of GRA in patients with Type 1 Diabetes, across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GRA

Snippet

Sponsor: University of California, San Diego | Conditions: Type 1 Diabetes Mellitus | Phase 1, Phase 2 | Status: COMPLETED